Name (Synonyms) | Correlation | |
---|---|---|
drug787 | Covid-19 Antibody testing (IgG and IgM) Wiki | 1.00 |
Name (Synonyms) | Correlation | |
---|---|---|
D045169 | Severe Acute Respiratory Syndrome NIH | 0.05 |
D018352 | Coronavirus Infections NIH | 0.04 |
Name (Synonyms) | Correlation |
---|
There is one clinical trial.
Prospective randomized trial to assess the antiviral efficacy of Pegylated Interferon Lambda (180 mcg SC injection) vs.placebo in up to 20 inpatient subjects with COVID-19 infection.
Description: Negative COVID PCR testing 7 days after first lambda dose
Measure: Undetectable COVID PCR at day 7 Time: 1 weekDescription: Negative COVID PCR testing 3, 5, 7 and 14 days after first lambda dose
Measure: Undetectable COVID PCR at day 3, 10 and 14 Time: 2 weeksDescription: Daily symptom score improvement during treatment period
Measure: Percentage of subjects on Lambda vs placebo with symptomatic improvement Time: 2 weeksDescription: Time to event for death, intubation, hospital discharge
Measure: Percentage of subjects on Lambda vs placebo with improved clinical outcomes Time: 2 weeks